Mersana Therapeutics, Inc. (MRSN)
NASDAQ: MRSN · Real-Time Price · USD
0.3437
-0.0053 (-1.52%)
At close: May 30, 2025, 4:00 PM
0.3440
+0.0003 (0.09%)
After-hours: May 30, 2025, 7:49 PM EDT

Mersana Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Revenue
34.0140.536.8626.580.040.83
Upgrade
Revenue Growth (YoY)
-11.21%9.88%38.65%61716.28%-94.81%-98.03%
Upgrade
Cost of Revenue
72.6873.02148.27173.39132.0167.04
Upgrade
Gross Profit
-38.67-32.52-111.41-146.8-131.97-66.21
Upgrade
Selling, General & Admin
38.1840.8159.5456.9636.8921.9
Upgrade
Operating Expenses
38.1840.8159.5456.9636.8921.9
Upgrade
Operating Income
-76.85-73.34-170.96-203.77-168.86-88.11
Upgrade
Interest Expense
-3.65-3.87-4.07-3.33-1.27-0.36
Upgrade
Interest & Investment Income
6.98.4412.072.880.070.42
Upgrade
EBT Excluding Unusual Items
-73.59-68.77-162.96-204.21-170.06-88.05
Upgrade
Merger & Restructuring Charges
---8.71---
Upgrade
Pretax Income
-73.59-68.77-171.67-204.21-170.06-88.05
Upgrade
Income Tax Expense
0.420.42----
Upgrade
Net Income
-74.01-69.19-171.67-204.21-170.06-88.05
Upgrade
Net Income to Common
-74.01-69.19-171.67-204.21-170.06-88.05
Upgrade
Shares Outstanding (Basic)
123123116947161
Upgrade
Shares Outstanding (Diluted)
123123116947161
Upgrade
Shares Change (YoY)
3.10%5.54%23.98%32.69%14.79%41.37%
Upgrade
EPS (Basic)
-0.60-0.56-1.48-2.18-2.41-1.43
Upgrade
EPS (Diluted)
-0.60-0.56-1.48-2.18-2.41-1.43
Upgrade
Free Cash Flow
-79.01-82.47-171.05-51.56-140.64-75.17
Upgrade
Free Cash Flow Per Share
-0.64-0.67-1.47-0.55-1.99-1.22
Upgrade
Gross Margin
-113.71%-80.31%----
Upgrade
Operating Margin
-225.98%-181.09%-463.86%-766.59%-392693.02%-10641.30%
Upgrade
Profit Margin
-217.63%-170.86%-465.80%-768.26%-395488.37%-10633.45%
Upgrade
Free Cash Flow Margin
-232.34%-203.65%-464.12%-193.97%-327060.47%-9078.38%
Upgrade
EBITDA
-75.33-71.71-169.44-202.84-168-87.1
Upgrade
EBITDA Margin
-221.51%-177.07%----
Upgrade
D&A For EBITDA
1.521.631.520.930.861.01
Upgrade
EBIT
-76.85-73.34-170.96-203.77-168.86-88.11
Upgrade
EBIT Margin
-225.98%-181.09%----
Upgrade
Updated May 15, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q